Senior Director, Global Medical Oncology, IO Thoracic / H&N Medical Product Lead at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Life sciences and/or healthcare professional training with an advanced degree (MD, PharmD, PhD)
  • Minimum of 7+ years working in the pharmaceutical industry (Medical Affairs/Medical Strategy, Clinical Research)
  • Experience in the thoracic cancer therapeutic area is preferred
  • Strong analytical skills
  • Strong scientific data and evidence interpretation + contextualization
  • Ability to work effectively with cross-functional teams including clinical, commercialization, regulatory, HEOR and Access
  • Excellent strategy development, critical thinking, decision making
  • Demonstrated ability to successfully create and implement strategies

Responsibilities

  • Develop and execute the WW & US Medical Affairs strategy for key assets
  • Act as the core medical representative for WW & US Program Teams
  • Manage a team of US Medical Scientists and Global Medical Leads to execute on the assigned book of work
  • Lead the cross-functional Asset/Indication Medical Strategy (AIMS) team
  • Ensure assets are positioned within the BMS disease area strategy
  • Participate in leadership activities to drive business priorities
  • Oversee asset development across multiple diseases
  • Develop and execute WW & US medical strategy, scientific narratives, and provide medical insights
  • Lead workstreams to identify evidence gaps and develop Integrated Evidence Plans
  • Deliver WW & US Medical Communications plans, including publications and symposia
  • Partner with colleagues in various departments to ensure proper communication of pipeline products and marketed medicines

Skills

Oncology
Immuno-Oncology
Medical Strategy
Thoracic Cancer
Head and Neck Cancer
Nivolumab
Ipilimumab
Relatlimab
Integrated Evidence Plans
Scientific Narratives
External Engagement
Advocacy
Cross-Functional Leadership
Clinical Data Interpretation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI